Healio Rheumatology Current Issue
The following articles appeared in the print edition of Healio Rheumatology.
Table of Contents
- A familiar fight against an unfamiliar foe: Rheumatologists brace for long COVID’s impact Rob Volansky
-
- Approximately 1 in 8 patients with COVID-19 experience long COVID Erich Martin
- Evusheld, aggressive therapy may reduce COVID-19 severity in patients on B-cell depletion Erich Martin
- FDA clears laser therapy to treat fibromyalgia pain
- FDA: Evusheld may lack efficacy against upcoming COVID-19 subvariants
- Non-bivalent COVID-19 boosters fail to protect against omicron in patients with ARDs Erich Martin
- ‘Our friend and our enemy’: Rheumatologists continue to grapple with steroids Rob Volansky
- Patients with AS receiving TNF inhibitors have lower rates of Alzheimer’s disease Erich Martin
- Pfizer COVID-19 vaccine offers similar protection in adolescents with, without IRDs Erich Martin
-
- Pre-arthritis methotrexate use improves RA course, fails to prevent clinical arthritis Erich Martin
- Regular metformin use slows knee osteoarthritis progression in patients with diabetes Erich Martin
- ‘Unprecedented’: How the Inflation Reduction Act of 2022 could impact rheumatology Rob Volansky
- Biosimilar-to-biosimilar switching safe, effective in rheumatology Erich Martin
- FDA approves upadacitinib for non-radiographic axial spondyloarthritis
- FDA grants fast-track designation for efzofitimod in systemic sclerosis-associated ILD Jason Laday
- Long COVID and me: A true story Leonard H. Calabrese, DO
- ACR: Patients on long-term glucocorticoids should receive oral bisphosphonates Erich Martin
-
- ACR report card: Most states still average a ‘C’ for rheumatology care access, cost Erich Martin
- Hooked on Rheum with Robert W. Levin, MD Robert W. Levin, MD
- Few ACR-, EULAR-endorsed guidelines backed up by head-to-head randomized clinical trials Erich Martin
- Infections more common in patients with RA receiving tofacitinib vs TNF inhibitors Erich Martin
- Litifilimab superior to placebo in reducing tender, swollen joints in lupus Erich Martin
- Patients with hip osteoarthritis may be at increased risk for stroke Erich Martin
- Patients with lupus who achieve remission, LDA less likely to accrue systemic damage Erich Martin
- TNF inhibitor use during pregnancy in RA reduces risk for low birth weight Erich Martin
-
- Better than ‘trial and error’: Treat-to-target beneficial in complex psoriatic arthritis Rob Volansky
- Cognitive dysfunction more common ‘than we want to admit’ in rheumatic disease Rob Volansky
- Deucravacitinib efficacious in treating systemic lupus erythematosus Gabrielle M. Grasso
- EULAR returning to onsite-only format for 2023 annual congress
- Patients with lupus ‘not doing as well as we would like’ despite new therapies Erich Martin
- Bipartisan bill would require residency programs to equitably assess DO, MD candidates Jason Laday
- Few patients with axial SpA have knowledge, skills for cardiorespiratory training Erich Martin
- Two-thirds of older adults with joint pain use OTC therapies to manage pain
-